Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a global outbreak. This was the first time many had ever heard of the virus, ...

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), developed by ...

Recent research at the University of Virginia could help provide an important clue as scientists scramble to find a way to treat the Ebola virus. One day after the first Ebola death in the United ...

Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure to ...

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a global outbreak. This was the first time many had ever heard of the virus, ...

Filoviruses—such as Ebola and Marburg viruses—can cause hemorrhagic fevers with up to 90% lethality. Not only that, but there are very few tools (vaccines or drugs) to combat them. Now, scientists at ...

The model on the left shows how the Ebola virus stalk has a compact conformation, which blocks the site where mAb 3A6 would bind. The model on the right shows how this portion of the stalk can adopt ...

On Sept 4, 2025, DR Congo declared its 16th Ebola virus outbreak. The epicentre of this outbreak occurred in the Kasai province—the first resurgence in this region since 2008.1 Genomic analysis ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

GENEVA ― Following a systematic review and meta-analysis of randomized clinical trials of the disease's therapeutics, the World Health Organization (WHO) has made strong recommendations for two ...